Search Finnegan

Articles

USPTO Patent Fee Changes for 2025 USPTO Patent Fee Changes for 2025

Prosecution First Blog

Changes to USPTO Patent Fees for 2025 Changes to USPTO Patent Fees for 2025

IP Updates

USPTO Patent Fees: Changes for 2025 USPTO Patent Fees: Changes for 2025

IP Updates

USPTO Issues Proposed Rulemaking Notice Relating to Terminal Disclaimer Practice USPTO Issues Proposed Rulemaking Notice Relating to Terminal Disclaimer Practice

Prosecution First Blog

Intrinsic Evidence Trumps Intrinsic Evidence Trumps

Webinar

Obvious-Type Double Patenting and PTEs: Defeating ODP Rejections and Avoiding Terminal Disclaimers Obvious-Type Double Patenting and PTEs: Defeating ODP Rejections and Avoiding Terminal Disclaimers

Prosecution First Blog

Novartis v. Ezra and Novartis v. Breckenridge: Cracks in the Armor of ODP Portending Well for Innovative Pharma? Novartis v. Ezra and Novartis v. Breckenridge: Cracks in the Armor of ODP Portending Well for Innovative Pharma?